Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ferric carboxymaltose by Vifor Pharma Management for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Ferric carboxymaltose is under clinical development by Vifor Pharma Management and currently in Phase III for Congestive Heart Failure (Heart...
Data Insights
Ferric carboxymaltose by Vifor Pharma Management for Restless Legs Syndrome: Likelihood of Approval
Ferric carboxymaltose is under clinical development by Vifor Pharma Management and currently in Phase III for Restless Legs Syndrome. According...